Macitentan
Cat. No.:YN320831
| 产品名称: | Macitentan | 
| CAS No.: | 441798-33-0 | 
| Chemical Name: | N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-sulfamide | 
| Synonyms: | 马西替坦; ACT-064992 | 
| 分子量: | 588.27 | 
| 分子式: | C₁₉H₂₀Br₂N₆O₄S | 
| SMILES: | BrC1=CN=C(OCCOC2=C(C3=CC=C(Br)C=C3)C(NS(NCCC)(=O)=O)=NC=N2)N=C1 | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Macitentan (ACT-064992) 是有口服活性,非多肽ETA和ETB(内皮素受体)双拮抗剂。Macitentan 有用于特发性肺纤维化和肺动脉高压的潜力。 | 
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
Iglarz, M., Binkert, C., Morrison, K., et al.Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistJ. Pharmacol. Exp. Ther.327(3),736-745(2008)
Lefaucheur, C., Loupy, A., and Zeevi, A.Complement-binding anti-HLA antibodies and kidney transplantationN. Engl. J. Med.370(1),85-86(2014)